title: Digital holographic microscopy for longitudinal volumetric imaging of growth and treatment response in three-dimensional tumor models.
abstract: We report the use of digital holographic microscopy (DHM) as a viable microscopy approach for quantitative, nondestructive longitudinal imaging of in vitro three-dimensional (3-D) tumor models. Following established methods, we prepared 3-D cultures of pancreatic cancer cells in overlay geometry on extracellular matrix beds and obtained digital holograms at multiple time points throughout the duration of growth. The holograms were digitally processed and the unwrapped phase images were obtained to quantify the nodule thickness over time under normal growth and in cultures subject to chemotherapy treatment. In this manner, total nodule volumes are rapidly estimated and demonstrated here to show contrasting time-dependent changes during growth and in response to treatment. This work suggests the utility of DHM to quantify changes in 3-D structure over time and suggests the further development of this approach for time-lapse monitoring of 3-D morphological changes during growth and in response to treatment that would otherwise be impractical to visualize.
authors.forename: Yuyu
authors.initials: Y
authors.lastname: Li
authors.forename: Ljubica
authors.initials: L
authors.lastname: Petrovic
authors.forename: Jeffrey
authors.initials: J
authors.lastname: La
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Celli
authors.forename: Chandra S
authors.initials: CS
authors.lastname: Yelleswarapu
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D045744:Cell Line, Tumor; D006696:Holography / Q000379:methods*; D006801:Humans; D021621:Imaging, Three-Dimensional / Q000379:methods*; D008853:Microscopy / Q000379:methods*; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology; D009944:Organoplatinum Compounds / Q000494:pharmacology / Q000627:therapeutic use; D000077150:Oxaliplatin
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin